Novel reverse genetics approach to probe cytoskeletal functions in mammalian oocytes

探测哺乳动物卵母细胞细胞骨架功能的新型反向遗传学方法

基本信息

  • 批准号:
    10018066
  • 负责人:
  • 金额:
    $ 7.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-13 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Actin cytoskeleton-based processes play crucial roles in meiosis in mammalian oocytes, including positioning of the meiotic spindle and asymmetric cell division. These events in oocytes are essential for reproductive success, as gene knockouts that impair these processes cause female infertility. The overall goal of the research proposed here is to analyze the roles of key proteins hypothesized to modulate function of the actin cytoskeleton during female meiosis. The hypotheses to be pursued here are based on our published data and on new unpublished data presented here. A second goal of this project is a technical one – to provide valuable proof-of-principle demonstration of the utility of a novel system for post- translational protein depletion, as an asset to the oocyte biology research community. Standard approaches for protein depletion that are used in oocytes (i.e., knockout, knockdown) have relatively little temporal precision for depletion of the target of interest. In contrast, consider the following example, from study in budding yeast. Chronic depletion of a protein via a null mutation merely produced a slow growth phenotype, whereas depletion at a specific stage of meiosis provided much sharper insights with a much more specific and interesting phenotype. This is the inspiration for the project proposed here. This research will use this same innovative approach – the auxin-inducible degradation (AID) system – to gain new insights into the mammalian oocyte's progression through meiosis. We show here that we have the AID system up and running in mouse oocytes. The overall concept for these studies is to express function- altering variants of proteins of interest (dominant-negative [DN] or constitutively-active [CA]) in wild-type oocytes to perturb function of a particular pathway. The AID system allows for degradation of this function- altering protein at different times of meiotic maturation (e.g., M-phase entry [nuclear envelope breakdown], early M-phase, late M-phase, etc.). In essence, this converts oocytes from a mutant state to wild-type at a time of our choosing, allowing temporal specificity in assessing protein function. We will use the AID system to analyze different stages of oocyte meiosis, from entry into M-phase of meiosis I to the conclusion of meiosis II. Thus, this project will be valuable not only for the discoveries it will provide, but also for the demonstration of AID system utility at multiple stages of meiosis. Aim 1 focusses on spindle positioning in meiosis I, and will determine the role of the actin-depolymerization protein cofilin through studies of when and where cofilin is required for spindle positioning. Aim 2 examines meiosis I, metaphase II arrest, and completion of meiosis II, and will test the hypothesis that inappropriate activity of the actin-to- membrane linker protein family known as ERMs impairs spindle function and polar body emission. Taken together, these studies will provide important insights to advance understanding of these crucial actin- dependent processes in oocytes, including leading to future work in in vivo models.
项目摘要 基于肌动蛋白的细胞分裂过程在哺乳动物卵母细胞减数分裂中起关键作用,包括 减数分裂纺锤体的定位和不对称的细胞分裂。卵母细胞中的这些事件对于 生殖成功,因为基因敲除会损害这些过程,导致女性不育。整体 本文提出的研究目标是分析假设调节功能的关键蛋白质的作用 肌动蛋白细胞骨架在女性减数分裂。这里要追求的假设是基于我们的 公布的数据和新的未公布的数据在这里。该项目的第二个目标是技术 一个-提供有价值的原理证明,证明一个新的系统的实用性, 翻译蛋白质消耗,作为卵母细胞生物学研究社区的资产。标准 用于卵母细胞的蛋白质消耗方法(即,击倒,击倒)相对较少 用于感兴趣的靶的耗尽的时间精度。相反,考虑以下示例,从 研究芽殖酵母。通过无效突变的蛋白质的慢性消耗仅仅产生了缓慢的生长 表型,而在减数分裂的特定阶段的消耗提供了更清晰的见解, 更具体和有趣的表型。这就是这里提出的项目的灵感。这 研究将使用同样的创新方法-生长素诱导降解(AID)系统-获得 哺乳动物卵母细胞减数分裂进程的新见解。我们在这里展示了 小鼠卵母细胞中的AID系统启动和运行。这些研究的总体概念是表达功能- 改变野生型中感兴趣的蛋白质的变体(显性阴性[DN]或组成型活性[CA]) 卵母细胞干扰特定途径的功能。AID系统允许降低这一功能- 在减数分裂成熟的不同时间改变蛋白质(例如,M期进入[核膜破裂], 早期M期、晚期M期等)。本质上,这将卵母细胞从突变状态转化为野生型 在我们选择的时间,允许评估蛋白质功能的时间特异性。我们将使用 AID系统分析卵母细胞减数分裂的不同阶段,从进入减数分裂I的M期到减数分裂的第二阶段。 减数分裂结束II。因此,这个项目的价值不仅在于它将提供的发现, 也用于证明AID系统在减数分裂的多个阶段的效用。Aim 1专注于主轴 定位在减数分裂I,并将确定肌动蛋白解聚蛋白cofilin的作用,通过 研究何时何地需要cofilin用于主轴定位。目的2检查减数分裂I,中期 II停滞,并完成减数分裂II,并将测试的假设,不适当的活动的肌动蛋白- 称为ERM的膜连接蛋白家族损害纺锤体功能和极体发射。采取 总之,这些研究将提供重要的见解,以促进对这些关键肌动蛋白的理解, 卵母细胞中的依赖过程,包括导致未来的工作在体内模型。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JANICE P EVANS其他文献

JANICE P EVANS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JANICE P EVANS', 18)}}的其他基金

The oocyte's progression through meiosis: Involvement of a heart disease-associated protein
卵母细胞减数分裂的进展:心脏病相关蛋白的参与
  • 批准号:
    10636839
  • 财政年份:
    2019
  • 资助金额:
    $ 7.75万
  • 项目类别:
The oocyte's progression through meiosis: Involvement of a heart disease-associated protein
卵母细胞减数分裂的进展:心脏病相关蛋白的参与
  • 批准号:
    10415975
  • 财政年份:
    2019
  • 资助金额:
    $ 7.75万
  • 项目类别:
The oocyte's progression through meiosis: Involvement of a heart disease-associated protein
卵母细胞减数分裂的进展:心脏病相关蛋白的参与
  • 批准号:
    10018056
  • 财政年份:
    2019
  • 资助金额:
    $ 7.75万
  • 项目类别:
The oocyte's progression through meiosis: Involvement of a heart disease-associated protein
卵母细胞减数分裂的进展:心脏病相关蛋白的参与
  • 批准号:
    10189671
  • 财政年份:
    2019
  • 资助金额:
    $ 7.75万
  • 项目类别:
p21-activated kinase as regulator of actin and microtubules in mammalian oocytes
p21 激活激酶作为哺乳动物卵母细胞肌动蛋白和微管的调节剂
  • 批准号:
    9387058
  • 财政年份:
    2017
  • 资助金额:
    $ 7.75万
  • 项目类别:
Signaling pathways that mediate mammalian oocyte cortical mechanics
介导哺乳动物卵母细胞皮质力学的信号通路
  • 批准号:
    8583163
  • 财政年份:
    2013
  • 资助金额:
    $ 7.75万
  • 项目类别:
Signaling pathways that mediate mammalian oocyte cortical mechanics
介导哺乳动物卵母细胞皮质力学的信号通路
  • 批准号:
    8701324
  • 财政年份:
    2013
  • 资助金额:
    $ 7.75万
  • 项目类别:
Novel approaches for disrupting gene expression in mammalian oocytes
破坏哺乳动物卵母细胞基因表达的新方法
  • 批准号:
    8195724
  • 财政年份:
    2011
  • 资助金额:
    $ 7.75万
  • 项目类别:
alpha-endosulfine in mammalian oocyte meiotic maturation
α-硫辛在哺乳动物卵母细胞减数分裂成熟中的作用
  • 批准号:
    8191837
  • 财政年份:
    2011
  • 资助金额:
    $ 7.75万
  • 项目类别:
2011 Fertilization and Activation of Development Gordon Research Conference
2011年施肥与发育激活戈登研究会议
  • 批准号:
    8198031
  • 财政年份:
    2011
  • 资助金额:
    $ 7.75万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了